Strides Pharma Science to raise funds through NCDs

21 Jul 2022 Evaluate

Strides Pharma Science is planning to raise funds through issuance of Non-Convertible Debentures (NCD) on a private placement basis. A meeting of the Committee of Directors is scheduled to be held on July 25, 2022, inter alia, to consider and approve the same.

Strides Pharma Science (Formerly Strides Shasun) is a pharmaceutical company with a major focus on development and manufacture of IP-led niche finished dosage formulations. It is also among the world’s largest manufacturers of soft gelatin capsules.

Strides Pharma Scien Share Price

783.50 -12.70 (-1.60%)
27-Jan-2026 10:52 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1634.35
Dr. Reddys Lab 1237.70
Cipla 1301.95
Zydus Lifesciences 889.20
Lupin 2136.10
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×